Chief Executive Officer
Vincent Milano has been Idera’s President and CEO, and a member of our board of directors, since 2014. Prior to joining Idera, Mr. Milano served as Chairman, President, and CEO of ViroPharma Incorporated, a pharmaceutical company that was acquired by Shire in 2014. Prior to being appointed CEO of ViroPharma, he served in increasing roles of responsibility in finance, administration, and operations, including as Chief Financial Officer and Chief Operating Officer. Prior to joining ViroPharma, Mr. Milano served in increasingly senior roles, most recently senior manager, at KPMG LLP, an independent registered public accounting firm, from 1985 to 1996.
Mr. Milano has also served on the boards of directors of Aclaris Therapeutics, Inc. since 2020, BioCryst Pharmaceuticals, Inc., since 2021, and VenatoRx Pharmaceuticals, Inc., since 2013. Mr. Milano previously served as a member of the boards of directors of Spark Therapeutics and Vanda Pharmaceuticals from 2014 to 2019 and 2010 to 2019, respectively.
Mr. Milano is also the Chairman of the Board for Life Science Cares Philadelphia, a collective effort of the life sciences industry to reduce the impact of poverty on its neighbors, and is a former member and chair of Life Sciences Pennsylvania, the state biotechnology industry association. He holds a Bachelor of Science degree in Accounting from Rider College.